Health Canada inspection
Shire Human Genetic Therapies Inc.: Health Canada inspection of Nov 21, 2024
Health Canada · GMP · rating C
Key facts
| Establishment | Shire Human Genetic Therapies Inc. |
|---|---|
| City | Cambridge |
| Province | MA |
| Country | United States |
| Program | GMP |
| Start date | Nov 18, 2024 |
| End date | Nov 21, 2024 |
| Rating | C |
| Rating description | Compliant |
| Licence number | Not applicable |
At a glance
- 1–9 Inspections of this establishment
- No Currently licensed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Health Canada inspections
Health Canada inspects establishments that conduct licensable activities with drugs, including good manufacturing practices (GMP) and pharmacovigilance (GVP) inspections. Clinical trial (GCP) inspections, which name individuals, are not published here.